Health Care & Life Sciences » Biotechnology | Kolon Life Science Inc.

Kolon Life Science Inc. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
20,395
5,060
27,009
137,852
78,825
Total Accounts Receivable
22,197
18,941
17,273
21,469
21,943
Inventories
43,285
42,592
36,251
34,734
46,532
Other Current Assets
971
2,265
1,845
2,761
3,676
Total Current Assets
86,848
68,857
82,379
196,816
150,976
Net Property, Plant & Equipment
108,257
113,064
116,686
125,562
144,249
Total Investments and Advances
3,951
14,659
15,681
14,548
400,523
Intangible Assets
6,302
10,793
13,404
14,801
20,133
Other Assets
1,251
1,309
-
1,092
917
Total Assets
206,898
208,896
228,616
358,972
716,797
ST Debt & Current Portion LT Debt
28,236
25,578
26,124
42,360
38,649
Accounts Payable
11,646
7,134
7,532
10,277
11,701
Income Tax Payable
1,613
56
229
418
-
Other Current Liabilities
4,806
4,768
4,556
17,157
12,705
Total Current Liabilities
46,301
37,536
38,441
70,212
63,056
Long-Term Debt
33,466
30,476
48,242
18,625
10,392
Provision for Risks & Charges
2,254
3,122
4,734
3,426
3,921
Deferred Taxes
289
214
467
1,753
90,763
Other Liabilities
-
-
845
953
1,225
Total Liabilities
82,021
71,133
92,261
97,615
169,357
Common Equity (Total)
123,628
136,175
135,442
259,788
545,412
Total Shareholders' Equity
123,628
136,175
135,442
259,788
545,412
Total Equity
123,628
136,175
135,442
259,788
545,412
Liabilities & Shareholders' Equity
206,898
208,896
228,616
358,972
716,797
Non-Equity Reserves
1,249
1,588
913
1,569
2,028

About Kolon Life Science

View Profile
Address
7th Floor, Kolon Tower Annex
Gwacheon-si GY 13837
Korea, Republic Of
Employees -
Website http://www.kolonls.co.kr
Updated 09/14/2018
KOLON Life Science, Inc. engages in the manufacture and sale of pharmaceuticals and environment materials. It operates through the Pharmaceuticals and Environment Businesses. The Pharmaceutical business provides cell and gene therapeutics.